Reclaiming drug discovery: why we need public pharma
Big Pharma thrives on profiting from publicly funded innovation: but Public Pharma can take back control and put health over profit.
Public Pharma: still a missing debate in mainstream academia
Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
29 years without Jonas Salk: against the normalization of the absurd
Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry
Presence of dengue in Europe raises public health concerns
An increase in local dengue transmissions reported by EU public health agencies has raised concerns about outbreak risks as climate change makes the region more suitable for Aedes mosquitoes
Public pharma infrastructure could give the world access to a treasure trove of medicines
Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers
Public pharma for Europe, a game-changer for access to medicines
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
